Find your local Needle and Syringe Program
The growth of GLP-1 treatment within diabetes Glucagon-like peptide 1 (GLP-1) receptor agonists have taken the healthcare world by storm, becoming one of the most successful drug classes of all time, reaching an astonishing $110 billion in sales in 2024 alone 1
The problem compounds when people do not eat enough protein
This is not BPC-157-specific
Energy-enhancing peptides This category of peptides is one Midi gets behind, particularly the FDA-approved peptide sermorelin, because we've seen it have a positive impact on some patients
Theyre popular in biohacking, bodybuilding, and regenerative medicine communities but not FDA-approved for human use sold as research chemicals. Evidence is mostly from animal studies, rodent models, and anecdotal reports